The presence of the disease was shown in the canine population for the first time in 2007 by indirect fluorescent antibody test (IFAT). The parasite circulation was confirmed also by direct diagnostic tools, as PCR, cytology and cultural method, performed on different bioptic materials.
This article, included in The Journal of Infectious Diseases special supplement on measles and rubella, provides an overview of the affected groups and the public settings in which measles transmission occurred in Europe in 2005–2009.
The authors present an appraisal of the pneumococcal epidemiological situation in 11 Central European countries. Data are based on study findings presented at the 12th Central European Vaccine Advisory Group (CEVAG) meeting, held on 21–22 May 2010 in Sofia, Bulgaria, and a literature review of the PubMed database.
During the Informal Meeting of Ministers of Health, 5-6th July, ECDC Director Marc Sprenger gives a speech presenting evidence of health inequalities in the EU, as well as several options for intervention.
European Food Safety Authority (EFSA) has issued a new report from its Task Force on the Shiga toxin-producing E. coli (STEC) outbreak in Germany and France. The Task Force has now concluded that one lot of fenugreek seeds imported from Egypt and used to produce sprouts is the most likely common link between the two outbreaks. EFSA continues to advise consumers not to grow sprouts for their own consumption and not to eat sprouts or sprouted seeds unless they have been cooked thoroughly.
In his speech to the Informal Health Council on 5th July, ECDC Director Marc Sprenger outlined the lessons learnt from the EHEC/STEC outbreak in EU, as well as the need to strengthen EU cooperation against epidemics.
ECDC has previously summarised information concerning the appearance of narcolepsy following the use of a specific pandemic vaccine (Pandemrix®) in children and adolescents in three European Countries.
The objective of WHO’s Global Influenza Vaccine Action Plan (which began in 2006) is to increase the use and supply of influenza vaccines on a routine basis.